GB1457671A - Flavour - Google Patents
FlavourInfo
- Publication number
- GB1457671A GB1457671A GB458774A GB458774A GB1457671A GB 1457671 A GB1457671 A GB 1457671A GB 458774 A GB458774 A GB 458774A GB 458774 A GB458774 A GB 458774A GB 1457671 A GB1457671 A GB 1457671A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- carbon atoms
- cycloalkyl
- atom
- cyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000796 flavoring agent Substances 0.000 title abstract 3
- 235000019634 flavors Nutrition 0.000 title abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 16
- 125000004432 carbon atom Chemical group C* 0.000 abstract 15
- -1 p-menth-3-yl group Chemical group 0.000 abstract 11
- 229910052799 carbon Inorganic materials 0.000 abstract 9
- 125000002947 alkylene group Chemical group 0.000 abstract 6
- 125000005078 alkoxycarbonylalkyl group Chemical class 0.000 abstract 5
- 125000004181 carboxyalkyl group Chemical class 0.000 abstract 5
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 5
- 125000002768 hydroxyalkyl group Chemical class 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 3
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 abstract 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 3
- 125000004122 cyclic group Chemical group 0.000 abstract 3
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- 239000001301 oxygen Substances 0.000 abstract 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- 241000208125 Nicotiana Species 0.000 abstract 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 abstract 1
- 125000002015 acyclic group Chemical group 0.000 abstract 1
- 239000003513 alkali Substances 0.000 abstract 1
- 150000001342 alkaline earth metals Chemical class 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 150000003863 ammonium salts Chemical class 0.000 abstract 1
- 235000013877 carbamide Nutrition 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 150000003950 cyclic amides Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000010348 incorporation Methods 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 1
- 239000003607 modifier Substances 0.000 abstract 1
- 210000000653 nervous system Anatomy 0.000 abstract 1
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical group [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000004437 phosphorous atom Chemical group 0.000 abstract 1
- 229910052698 phosphorus Inorganic materials 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 150000003456 sulfonamides Chemical class 0.000 abstract 1
- 125000001174 sulfone group Chemical group 0.000 abstract 1
- 150000003509 tertiary alcohols Chemical group 0.000 abstract 1
- 150000003511 tertiary amides Chemical class 0.000 abstract 1
- 150000003672 ureas Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/40—Tea flavour; Tea oil; Flavouring of tea or tea extract
- A23F3/405—Flavouring with flavours other than natural tea flavour or tea oil
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F5/00—Coffee; Coffee substitutes; Preparations thereof
- A23F5/46—Coffee flavour; Coffee oil; Flavouring of coffee or coffee extract
- A23F5/465—Flavouring with flavours other than natural coffee flavour or coffee oil
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
Landscapes
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Seasonings (AREA)
- Non-Alcoholic Beverages (AREA)
- Dairy Products (AREA)
- Confectionery (AREA)
- Tea And Coffee (AREA)
- Jellies, Jams, And Syrups (AREA)
- Manufacture Of Tobacco Products (AREA)
Abstract
1457671 Flavour modifiers WILKINSON SWORD Ltd 29 Jan 1975 [31 Jan 1974 18 April 1974] 04587/74 and 17088/74 Headings A2B and A2C The flavour of ingestible preparations including tobacco is modified by incorporation therein of a compound capable of stimulating the cold receptors of the nervous system of the body when brought into contact therewith but being incorporated into the preparation in an amount below the threshold of practical physiological cooling activity (as hereinbefore defined), said compound being a compound of the formula where, in formula I, R 1 is H or C 1 -C 6 alkyl, R 2 and R 3 , when taken separately, are each alkyl or cycloalkyl of up to 6 carbon atoms, or up to 7 when X is OH or CH 2 OH, R 2 and R 3 , when taken together, represent a C 4 -C 11 straight or branched chain alkylene group, it being provided that: i) when R 1 is H then the alkylene group is branched at a carbon atom in a beta or gamma position relative to the group X; ii) that when X is OH or CH 2 OH, then said alkylene group may contain an OH substituent; and iii) that when R, is H and X is OH, then the cyclic group represented by is other than a p-menth-3-yl group; R 1 , R 2 and R 3 together provide a total of from 6-18 carbon atoms; X is COOR 7 , CONR 8 R 9 , SO x NR 8 R 9 or SO x R 10 ; R 7 is H, an alkali or alkaline earth metal, ammonium, alkyl- or hydroxyalkyl-substituted ammonium, or a hydroxyalkyl, hydroxyalkoxyalkyl, carboxyalkyl or alkoxycarbonylalkyl group of up to 12 carbon atoms; R 8 and R 9 , when taken separately, are each H or alkyl, hydroxyalkyl, carboxyalkyl or alkoxycarbonylalkyl of up to 12 carbon atoms, with the proviso that when R 8 is H, R 9 may also be cycloalkyl of up to 8 carbon atoms, phenyl or benzyl, or substituted phenyl or benzyl containing hydroxy, C 1 -C 4 alkyl or C 1 -C 4 alkoxy substituents; R 8 and R 9 , when taken together represent an alkylene group of up to 12 carbon atoms, the carbon atom chain of which may optionally be interrupted by oxygen or an -NH- group; R 10 is alkyl, hydroxyalkyl, carboxyalkyl or alkoxycarbonylalkyl of up to 12 carbon atoms; and x is 1 or 2; and where in formula II, R 4 is C 3 -C 20 alkyl; R 5 is C 3 -C 8 alkyl or cycloalkyl; R 6 is C 1 -C 8 alkyl or C 3 -C 8 cycloalkyl or alkylcycloalkyl; it being provided that at least one of R 4 , R 5 and R 6 is branched at a carbon atom in an α, # or γ position relative to the phosphorus atom, and that R 4 , R 5 and R 6 together provide a total of from 10-24 carbon atoms; and where, in formula III, R 11 when taken separately, is H, C 1 -C 6 alkyl or C 3 -C 6 cycloalkyl; R 12 , when taken separately, is C 3 -C 10 alkyl or C 3 -C 10 alkylcycloalkyl, cycloalkyl, or cycloalkylalkyl, with the proviso that R 12 is branched at an α- or #-carbon atom relative to the N atom, this condition to be satisfied, in the case of cyclic groups, when the carbon atom α- or #- to the N atom is part of the cycle; R 11 and R 12 , when taken together, represent a branched chain alkylene group having 3-7 carbon atoms and branching at an α- or #-carbon atom relative to the N atom, and the chain optionally containing an ether (-O-) oxygen atom; R 11 and R 12 when separate groups and when taken together provide a total of at least 5 carbon atoms; Y represents R 13 CO-, R 14 SO 2 - or R 15 R 16 NOC-; R 13 is H, C 1 -C 6 alkyl or alkenyl, C 3 -C 6 cycloalkyl C 1 -C 10 hydroxyalkyl, C 2 -C 10 carboxyalkyl, C 3 -C 10 alkoxycarbonylalkyl, phenyl or phenyl containing C 1 -C 4 alkyl, alkoxy, OH, COOH or NO 2 substituents, with the proviso that when R 13 is C 6 alkyl it is primary in structure; R 14 is C 1 -C 6 alkyl or C 3 -C 6 cycloalkyl, with the proviso that when R 14 is C 5 or C 6 alkyl it is primary in structure; R 15 and R 16 , when taken separately, are each H, C 1 -C 6 alkyl, C 3 -C 6 alkylcycloalkyl, cycloalkyl, or cycloalkylalkyl, C 1 -C 10 hydroxyalkyl, C 2 -C 10 carboxyalkyl or C 3 -C 10 alkoxycarbonylalkyl; or together represent a straight or branched chain C 3 -C 10 alkylene group optionally substituted with oxygen or an oxygen-containing group or containing an ether oxygen atom; and R 11 , R 12 and Y provide a total of from 7-16 carbon atoms. The following classes of compounds fall within the given formulae: cyclic amides, acyclic secondary and tertiary amides, cyclic carboxylic acids, salts and esters, cyclic sulphonamides and sulphinamides, acyclic sulphonamides and sulphinamides, cyclic and acyclic sulphoxides and sulphones, phosphine oxides, acyclic secondary and tertiary alcohols, cyclic alcohols, methylol compounds substituted ureas, amides, sulphonamides, p-methane diols, and acyclic carboxylic acids, salts and esters. Exhaustive lists are included in the specification.
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB458774A GB1457671A (en) | 1974-01-31 | 1974-01-31 | Flavour |
| CA218,377A CA1055772A (en) | 1974-01-31 | 1975-01-21 | Flavour modifiers |
| ZA00750394A ZA75394B (en) | 1974-01-31 | 1975-01-21 | Flavour modifiers |
| AU77548/75A AU7754875A (en) | 1974-01-31 | 1975-01-23 | Flavour modifiers |
| IL46502A IL46502A0 (en) | 1974-01-31 | 1975-01-24 | Flavour modifiers |
| DE19752503555 DE2503555A1 (en) | 1974-01-31 | 1975-01-29 | METHOD FOR MODIFYING THE TASTE OF INGESTABLE SUBSTANCES |
| JP50012289A JPS50111264A (en) | 1974-01-31 | 1975-01-29 | |
| LU71748A LU71748A1 (en) | 1974-01-31 | 1975-01-29 | |
| DK31575*#A DK31575A (en) | 1974-01-31 | 1975-01-30 | |
| NL7501135A NL7501135A (en) | 1974-01-31 | 1975-01-30 | METHOD FOR MODELING THE TASTE SCENT OF ORAL MATERIALS, THE METHOD FOR PREPARING FLAVOR FRAGRANCE COMPOSITIONS. |
| FR7502883A FR2272610B3 (en) | 1974-01-31 | 1975-01-30 | |
| BE2054121A BE825025A (en) | 1974-01-31 | 1975-01-31 | AROMA MODIFIERS |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB458774A GB1457671A (en) | 1974-01-31 | 1974-01-31 | Flavour |
| GB1708874 | 1974-04-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1457671A true GB1457671A (en) | 1976-12-08 |
Family
ID=26239244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB458774A Expired GB1457671A (en) | 1974-01-31 | 1974-01-31 | Flavour |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS50111264A (en) |
| AU (1) | AU7754875A (en) |
| CA (1) | CA1055772A (en) |
| DE (1) | DE2503555A1 (en) |
| DK (1) | DK31575A (en) |
| FR (1) | FR2272610B3 (en) |
| GB (1) | GB1457671A (en) |
| IL (1) | IL46502A0 (en) |
| NL (1) | NL7501135A (en) |
Cited By (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6214788B1 (en) | 1999-03-31 | 2001-04-10 | Firmenich Sa | Use of cubebol as a flavoring ingredient |
| WO2005049553A1 (en) * | 2003-11-21 | 2005-06-02 | Givaudan Sa | N-substituted p-menthane carbosamided |
| WO2005097735A1 (en) * | 2004-04-02 | 2005-10-20 | Millennium Specialty Chemicals | Physiological cooling compositions containing highly purified ethyl ester of n-[[5-methyl-2-(1-methylethyl)cyclohexyl)carbonyl]glycine |
| WO2006056087A1 (en) * | 2004-11-23 | 2006-06-01 | Givaudan Sa | Carboxamides and their use |
| WO2006084184A3 (en) * | 2005-02-04 | 2006-11-30 | Senomyx Inc | Molecules comprising linked organic moieties as flavor modifiers for comestible compositions |
| US7417048B2 (en) | 2003-12-31 | 2008-08-26 | Wei Edward T | Aryl-substituted derivatives of cycloalkyl and branched chain alkyl carboxylic acids useful as antinociceptive drugs for peripheral targets |
| US7476399B2 (en) | 2003-08-06 | 2009-01-13 | Senomyx Inc. | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| WO2008141469A3 (en) * | 2007-05-23 | 2009-05-07 | Givaudan Sa | Butone derivatives useful as cooling agents |
| EP2186506A1 (en) * | 2009-10-06 | 2010-05-19 | Symrise GmbH & Co. KG | Teeth cleaning compound containing menthol with reduced bitter sensation |
| US7842324B2 (en) | 2005-06-15 | 2010-11-30 | Senomyx, Inc. | Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers |
| US7893072B2 (en) | 2003-07-02 | 2011-02-22 | Genentech, Inc. | Trp-p8 active compounds and therapeutic treatment methods |
| US8343945B2 (en) | 2007-12-07 | 2013-01-01 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| US8362091B2 (en) | 2003-08-04 | 2013-01-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US8377422B2 (en) | 2007-12-07 | 2013-02-19 | Givaudan S.A. | Carboxamide derivatives having cooling properties |
| US8435498B2 (en) | 2002-10-25 | 2013-05-07 | Foamix Ltd. | Penetrating pharmaceutical foam |
| US8486375B2 (en) | 2003-04-28 | 2013-07-16 | Foamix Ltd. | Foamable compositions |
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| US8518378B2 (en) | 2003-08-04 | 2013-08-27 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US8618081B2 (en) | 2009-10-02 | 2013-12-31 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US8664261B2 (en) | 2009-05-05 | 2014-03-04 | Givaudan S.A. | Organic compounds having cooling properties |
| US8709385B2 (en) | 2008-01-14 | 2014-04-29 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| US8722021B2 (en) | 2002-10-25 | 2014-05-13 | Foamix Ltd. | Foamable carriers |
| US8784782B2 (en) | 2005-02-04 | 2014-07-22 | Senomyx, Inc. | Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| US8795635B2 (en) | 2006-11-14 | 2014-08-05 | Foamix Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
| US9072313B2 (en) | 2006-04-21 | 2015-07-07 | Senomyx, Inc. | Comestible compositions comprising high potency savory flavorants, and processes for producing them |
| US9072667B2 (en) | 2009-07-29 | 2015-07-07 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9167813B2 (en) | 2009-07-29 | 2015-10-27 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US9320705B2 (en) | 2002-10-25 | 2016-04-26 | Foamix Pharmaceuticals Ltd. | Sensation modifying topical composition foam |
| US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
| US9446267B2 (en) | 2009-10-06 | 2016-09-20 | Symrise Ag | Products comprising a flavoring agent composition |
| US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
| US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US20180179147A1 (en) * | 2015-06-04 | 2018-06-28 | Pinova Holdings, Inc. | Physiological cooling compounds |
| US10299999B2 (en) | 2011-02-23 | 2019-05-28 | Givaudan S.A. | Flavour composition comprising menthol and menthane carboxamides |
| US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3724900C2 (en) * | 1986-08-08 | 2000-04-06 | Colgate Palmolive Co | N-Alkylneoalkanamide and their use |
| CA2959231C (en) * | 2013-10-22 | 2022-06-21 | Edward Tak Wei | Di-isopropyl-phosphinoyl-alkane (dapa) compounds as topical agents for the treatment of sensory discomfort |
| JP6564498B2 (en) * | 2018-06-06 | 2019-08-21 | エドワード タク ウェイWEI, Edward Tak | Di-isopropyl-alkane (DAPA) compounds as topical agents for the treatment of sensory discomfort |
-
1974
- 1974-01-31 GB GB458774A patent/GB1457671A/en not_active Expired
-
1975
- 1975-01-21 CA CA218,377A patent/CA1055772A/en not_active Expired
- 1975-01-23 AU AU77548/75A patent/AU7754875A/en not_active Expired
- 1975-01-24 IL IL46502A patent/IL46502A0/en unknown
- 1975-01-29 JP JP50012289A patent/JPS50111264A/ja active Pending
- 1975-01-29 DE DE19752503555 patent/DE2503555A1/en active Pending
- 1975-01-30 NL NL7501135A patent/NL7501135A/en unknown
- 1975-01-30 DK DK31575*#A patent/DK31575A/da unknown
- 1975-01-30 FR FR7502883A patent/FR2272610B3/fr not_active Expired
Cited By (114)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6214788B1 (en) | 1999-03-31 | 2001-04-10 | Firmenich Sa | Use of cubebol as a flavoring ingredient |
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US8722021B2 (en) | 2002-10-25 | 2014-05-13 | Foamix Ltd. | Foamable carriers |
| US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
| US9713643B2 (en) | 2002-10-25 | 2017-07-25 | Foamix Pharmaceuticals Ltd. | Foamable carriers |
| US8840869B2 (en) | 2002-10-25 | 2014-09-23 | Foamix Ltd. | Body cavity foams |
| US8741265B2 (en) | 2002-10-25 | 2014-06-03 | Foamix Ltd. | Penetrating pharmaceutical foam |
| US9492412B2 (en) | 2002-10-25 | 2016-11-15 | Foamix Pharmaceuticals Ltd. | Penetrating pharmaceutical foam |
| US8435498B2 (en) | 2002-10-25 | 2013-05-07 | Foamix Ltd. | Penetrating pharmaceutical foam |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US10322085B2 (en) | 2002-10-25 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US11033491B2 (en) | 2002-10-25 | 2021-06-15 | Vyne Therapeutics Inc. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US9320705B2 (en) | 2002-10-25 | 2016-04-26 | Foamix Pharmaceuticals Ltd. | Sensation modifying topical composition foam |
| US10821077B2 (en) | 2002-10-25 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US8486375B2 (en) | 2003-04-28 | 2013-07-16 | Foamix Ltd. | Foamable compositions |
| US7893072B2 (en) | 2003-07-02 | 2011-02-22 | Genentech, Inc. | Trp-p8 active compounds and therapeutic treatment methods |
| US8518378B2 (en) | 2003-08-04 | 2013-08-27 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US9636405B2 (en) | 2003-08-04 | 2017-05-02 | Foamix Pharmaceuticals Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| US9101662B2 (en) | 2003-08-04 | 2015-08-11 | Foamix Pharmaceuticals Ltd. | Compositions with modulating agents |
| US9050253B2 (en) | 2003-08-04 | 2015-06-09 | Foamix Pharmaceuticals Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US8362091B2 (en) | 2003-08-04 | 2013-01-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| US8703105B2 (en) | 2003-08-04 | 2014-04-22 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US9091686B2 (en) | 2003-08-06 | 2015-07-28 | Senomyx, Inc. | Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides |
| US11268952B2 (en) | 2003-08-06 | 2022-03-08 | Firmenich Incorporated | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| US10557845B2 (en) | 2003-08-06 | 2020-02-11 | Firmenich Incorporated | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| US7888470B2 (en) | 2003-08-06 | 2011-02-15 | Senomyx, Inc. | Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides |
| US8124121B2 (en) | 2003-08-06 | 2012-02-28 | Senomyx, Inc. | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| US9459250B2 (en) | 2003-08-06 | 2016-10-04 | Senomyx, Inc. | Use of T1R3 venus flytrap region polypeptide to screen for taste modulators |
| US8735081B2 (en) | 2003-08-06 | 2014-05-27 | Senomyx, Inc. | T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| US10352929B2 (en) | 2003-08-06 | 2019-07-16 | Senomyx, Inc. | T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| US7476399B2 (en) | 2003-08-06 | 2009-01-13 | Senomyx Inc. | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| US8895050B2 (en) | 2003-08-06 | 2014-11-25 | Senomyx, Inc. | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| US10060909B2 (en) | 2003-08-06 | 2018-08-28 | Senomyx, Inc. | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| US8404455B2 (en) | 2003-08-06 | 2013-03-26 | Senomyx, Inc. | Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides |
| US7414152B2 (en) | 2003-11-21 | 2008-08-19 | Givaudan, Sa | N-substituted p-menthane carboxamides |
| USRE44339E1 (en) | 2003-11-21 | 2013-07-02 | Givaudan S.A. | N-substituted P-menthane carboxamides |
| WO2005049553A1 (en) * | 2003-11-21 | 2005-06-02 | Givaudan Sa | N-substituted p-menthane carbosamided |
| US7417048B2 (en) | 2003-12-31 | 2008-08-26 | Wei Edward T | Aryl-substituted derivatives of cycloalkyl and branched chain alkyl carboxylic acids useful as antinociceptive drugs for peripheral targets |
| CN102731338A (en) * | 2004-04-02 | 2012-10-17 | 瑞内森兹有限责任公司 | Physiological cooling compositions containing highly purified ethyl ester of n-[[5-methyl-2-(1-methylethyl)cyclohexyl)carbonyl]glycine |
| WO2005097735A1 (en) * | 2004-04-02 | 2005-10-20 | Millennium Specialty Chemicals | Physiological cooling compositions containing highly purified ethyl ester of n-[[5-methyl-2-(1-methylethyl)cyclohexyl)carbonyl]glycine |
| WO2006056087A1 (en) * | 2004-11-23 | 2006-06-01 | Givaudan Sa | Carboxamides and their use |
| WO2006084184A3 (en) * | 2005-02-04 | 2006-11-30 | Senomyx Inc | Molecules comprising linked organic moieties as flavor modifiers for comestible compositions |
| US8968708B2 (en) | 2005-02-04 | 2015-03-03 | Senomyx, Inc. | Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions |
| US8784782B2 (en) | 2005-02-04 | 2014-07-22 | Senomyx, Inc. | Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions |
| US7842324B2 (en) | 2005-06-15 | 2010-11-30 | Senomyx, Inc. | Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers |
| US9072313B2 (en) | 2006-04-21 | 2015-07-07 | Senomyx, Inc. | Comestible compositions comprising high potency savory flavorants, and processes for producing them |
| US8795635B2 (en) | 2006-11-14 | 2014-08-05 | Foamix Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US9682021B2 (en) | 2006-11-14 | 2017-06-20 | Foamix Pharmaceuticals Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| WO2008141469A3 (en) * | 2007-05-23 | 2009-05-07 | Givaudan Sa | Butone derivatives useful as cooling agents |
| US7935848B2 (en) | 2007-05-23 | 2011-05-03 | Givaudan S.A. | Butone derivatives useful as cooling agents |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US10369102B2 (en) | 2007-08-07 | 2019-08-06 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US11103454B2 (en) | 2007-08-07 | 2021-08-31 | Vyne Therapeutics Inc. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US9662298B2 (en) | 2007-08-07 | 2017-05-30 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
| US8343945B2 (en) | 2007-12-07 | 2013-01-01 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| US9549898B2 (en) | 2007-12-07 | 2017-01-24 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
| US8377422B2 (en) | 2007-12-07 | 2013-02-19 | Givaudan S.A. | Carboxamide derivatives having cooling properties |
| US9161916B2 (en) | 2007-12-07 | 2015-10-20 | Foamix Pharmaceuticals Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| US9795564B2 (en) | 2007-12-07 | 2017-10-24 | Foamix Pharmaceuticals Ltd. | Oil-based foamable carriers and formulations |
| US11433025B2 (en) | 2007-12-07 | 2022-09-06 | Vyne Therapeutics Inc. | Oil foamable carriers and formulations |
| US8900553B2 (en) | 2007-12-07 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
| US8709385B2 (en) | 2008-01-14 | 2014-04-29 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| US10588858B2 (en) | 2009-04-28 | 2020-03-17 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US10213384B2 (en) | 2009-04-28 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US10363216B2 (en) | 2009-04-28 | 2019-07-30 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US8664261B2 (en) | 2009-05-05 | 2014-03-04 | Givaudan S.A. | Organic compounds having cooling properties |
| US11219631B2 (en) | 2009-07-29 | 2022-01-11 | Vyne Pharmaceuticals Inc. | Foamable compositions, breakable foams and their uses |
| US9167813B2 (en) | 2009-07-29 | 2015-10-27 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9572775B2 (en) | 2009-07-29 | 2017-02-21 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9072667B2 (en) | 2009-07-29 | 2015-07-07 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| US10092588B2 (en) | 2009-07-29 | 2018-10-09 | Foamix Pharmaceuticals Ltd. | Foamable compositions, breakable foams and their uses |
| US10350166B2 (en) | 2009-07-29 | 2019-07-16 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| US8945516B2 (en) | 2009-10-02 | 2015-02-03 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US8865139B1 (en) | 2009-10-02 | 2014-10-21 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10238746B2 (en) | 2009-10-02 | 2019-03-26 | Foamix Pharmaceuticals Ltd | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US10265404B2 (en) | 2009-10-02 | 2019-04-23 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US12138311B2 (en) | 2009-10-02 | 2024-11-12 | Journey Medical Corporation | Topical tetracycline compositions |
| US10137200B2 (en) | 2009-10-02 | 2018-11-27 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US10322186B2 (en) | 2009-10-02 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US8618081B2 (en) | 2009-10-02 | 2013-12-31 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US9675700B2 (en) | 2009-10-02 | 2017-06-13 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10086080B2 (en) | 2009-10-02 | 2018-10-02 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US8871184B2 (en) | 2009-10-02 | 2014-10-28 | Foamix Ltd. | Topical tetracycline compositions |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| US10463742B2 (en) | 2009-10-02 | 2019-11-05 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10517882B2 (en) | 2009-10-02 | 2019-12-31 | Foamix Pharmaceuticals Ltd. | Method for healing of an infected acne lesion without scarring |
| US8992896B2 (en) | 2009-10-02 | 2015-03-31 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10213512B2 (en) | 2009-10-02 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10610599B2 (en) | 2009-10-02 | 2020-04-07 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10821187B2 (en) | 2009-10-02 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US10029013B2 (en) | 2009-10-02 | 2018-07-24 | Foamix Pharmaceuticals Ltd. | Surfactant-free, water-free formable composition and breakable foams and their uses |
| US10835613B2 (en) | 2009-10-02 | 2020-11-17 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US10967063B2 (en) | 2009-10-02 | 2021-04-06 | Vyne Therapeutics Inc. | Surfactant-free, water-free formable composition and breakable foams and their uses |
| US10946101B2 (en) | 2009-10-02 | 2021-03-16 | Vyne Therapeutics Inc. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| EP2364689A3 (en) * | 2009-10-06 | 2015-12-09 | Symrise AG | Teeth cleaning compound containing menthol with reduced bitter sensation |
| EP2186506A1 (en) * | 2009-10-06 | 2010-05-19 | Symrise GmbH & Co. KG | Teeth cleaning compound containing menthol with reduced bitter sensation |
| US9446267B2 (en) | 2009-10-06 | 2016-09-20 | Symrise Ag | Products comprising a flavoring agent composition |
| US10299999B2 (en) | 2011-02-23 | 2019-05-28 | Givaudan S.A. | Flavour composition comprising menthol and menthane carboxamides |
| US10981862B2 (en) * | 2015-06-04 | 2021-04-20 | Symrise, Inc. | Physiological cooling compounds |
| US20180179147A1 (en) * | 2015-06-04 | 2018-06-28 | Pinova Holdings, Inc. | Physiological cooling compounds |
| US10849847B2 (en) | 2016-09-08 | 2020-12-01 | Foamix Pharamaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| US11324691B2 (en) | 2016-09-08 | 2022-05-10 | Journey Medical Corporation | Compositions and methods for treating rosacea and acne |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2272610B3 (en) | 1977-10-21 |
| DK31575A (en) | 1975-09-22 |
| AU7754875A (en) | 1976-07-29 |
| CA1055772A (en) | 1979-06-05 |
| DE2503555A1 (en) | 1975-08-14 |
| IL46502A0 (en) | 1975-04-25 |
| FR2272610A1 (en) | 1975-12-26 |
| NL7501135A (en) | 1975-08-04 |
| JPS50111264A (en) | 1975-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1457671A (en) | Flavour | |
| GB1461209A (en) | Thienyl and thietyl compounds | |
| MY102852A (en) | O/w type emulsion composition. | |
| IE35501L (en) | Herbicidal n-phosphonomethyl glycine compounds | |
| GB1535145A (en) | Low irritant shampoo composition | |
| ES8301951A1 (en) | Thiazolidine derivatives and their production and medicinal compositions containing them. | |
| ES8300768A1 (en) | Trisubstituted pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them. | |
| HUT38921A (en) | Process for producing antitussive and slime-regulating 2-substituted thiazolidine derivatives and pharmaceutical compositions containing them as active agents | |
| ES8502977A1 (en) | Pilocarpine prodrugs. | |
| ES457783A1 (en) | Basic substituted xanthine derivatives | |
| ES8201955A1 (en) | 2-Hydroxyoxanilic acid derivatives and salts, their preparation and pharmaceutical compositions containing them. | |
| GB1227006A (en) | ||
| ES479570A1 (en) | 7 alpha -Methoxycephalosporin derivatives and their pharmaceutical compositions having antibacterial activity | |
| GB1380675A (en) | N-acylaminomethyl-phosphonates and their use as flame-proofing agents | |
| ES8304133A1 (en) | Triazoloquinazolinone derivatives and their acid addition salts, their preparation, their use as medicaments and compositions containing them. | |
| ES455940A1 (en) | 2,9-Dioxatricyclo{8 4,3,1,0{hu 3,7{b {9 {0 decane derivatives and pharmaceutical compositions thereof | |
| GB1455630A (en) | Tobacco compositions comprising monoesters of mono- and di- alkylmalonates | |
| GB1207588A (en) | Acyl derivatives of hydroxy and polyesters and their use as baked goods additives | |
| GB1514077A (en) | Treatment of mycoplasmosis | |
| GB1394791A (en) | Diphenylalkyllactamimide derivatives | |
| EP0042669A3 (en) | Compounds and compositions for use in animal feeds | |
| GB1502706A (en) | Flavour of flavour-containing ingestible preparations including tobacco | |
| ES8202332A1 (en) | Pharmaceutically acceptable salts of 4'-(9-acridinylamino) methanesulfon-m-anisidide, their production, and pharmaceutical compositions containing such salts. | |
| ES8201539A1 (en) | Orthoarylideneaminophenethylamines and pharmaceutical compositions | |
| IE44708L (en) | Esters of hydroxy alkoxyalkyl purines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |